EFTA
Search
Search
Entities
About
Settings
/
to search
Search
Search syntax help
Dataset
Set 1
Set 2
Set 3
Set 4
Set 5
Set 6
Set 7
Set 8
Set 9
Set 10
Set 11
Set 12
Sort
Relevance
Most pages
Most words
Dataset
Newest
Oldest
Status
All
Extracted
Failed
DOJ Status
All
Removed
Available
Date Range
Undated only
–
Page Count
–
Saved Searches
+
2 results for “
"Januvia"
”
Export
EFTA00847263
Set 9
2015-09-02
2p
426w
Suisse Rating, Target Price: Neutral, S61 Potential Stock Upside: 11% Upcoming Catalyst: MRK's
Januvia
franchise will likely feel pressure from the positive EMPA-REG OUTCOME data but we expect
https://www.justice.gov/epstein/files/DataSet%209/EFTA00847263.pdf
EFTA02400583
Keyboard Shortcuts
/
Focus search
Esc
Blur input
O
Open PDF
←
→
Paginate
Set 11
2013-02-13
2p
446w
total, while the U.S. represents - 38%. Highest selling products inc=ude: Singulair (asthma/allergies) and
Januvia
(diabetes)=/p> • =nbsp; Pullback presents opportunity in a favored sector (the cheapest d=fensive sector
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02400583.pdf
Corpus: 1990-03-17 – 2025-12-01
←
September 2015
→
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Undated
(150,429)
None
Light
Medium
Heavy
Results by Dataset
2 total
Set 9
1
Set 11
1